ERBB2 and breast carcinoma: As shown in the previous analyses, four metabolites (histidine, lactate, serine, and taurine) were individually associated with disease-free survival, even after adjustment for hormones, other noncollinear metabolites, and known risk factors for breast cancer relapse (steroid receptor and HER-2 status).